Serum Zinc, Peptic Ulcer Disease and H. Pylori Infection
Sponsor
Ain Shams University (Other)
Overall Status
Completed
CT.gov ID
NCT02716025
Collaborator
(none)
75
22
Study Details
Study Description
Brief Summary
Fifty consecutive patients with symptoms suggestive of peptic ulcer disease were included. All underwent complete clinical evaluation, laboratory investigations, upper gastrointestinal endoscopy and rapid urease test. Measurement of serum zinc level was done for all the included patients in addition to twenty five age and sex matched healthy control subjects.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
75 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Study Start Date
:
Oct 1, 2013
Actual Primary Completion Date
:
Aug 1, 2015
Actual Study Completion Date
:
Aug 1, 2015
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Case Group
|
Procedure: Upper gastrointestinal endoscopy
Thorough examination of the esophagus, stomach and duodenum to the second part was done to all patients using Olympus CV-150 or Pentax EPM-3500.
|
Control Group
|
Outcome Measures
Primary Outcome Measures
- Detection of positive upper GIT endoscopic findings [upon endoscopy]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Symptoms suggestive of peptic ulcer disease like epigastric pain, dyspepsia, heartburn
Exclusion Criteria:
-
Patients who received zinc supplementation, proton pump inhibitors (PPI), non-steroidal anti-inflammatory drugs (NSAIDs)
-
Those presented with hematemesis or melena
-
Those with chronic liver disease, renal failure, malabsorption or previous gastric surgery
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Ain Shams University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Sara Abdelhakam,
Assistant Professor,
Ain Shams University
ClinicalTrials.gov Identifier:
NCT02716025
Other Study ID Numbers:
- 811
First Posted:
Mar 22, 2016
Last Update Posted:
Mar 22, 2016
Last Verified:
Mar 1, 2016
Additional relevant MeSH terms: